| Ms Vida Landa, MED, MS, CCC-SLP | |
|
102 N Jordan Ave, Miles City, MT 59301-3717 | |
| (406) 853-2971 | |
| Not Available |
| Full Name | Ms Vida Landa |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 102 N Jordan Ave, Miles City, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992916944 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 910 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Vida Landa, MED, MS, CCC-SLP Po Box 1427, Miles City, MT 59301-1427 Ph: (406) 853-2971 | Ms Vida Landa, MED, MS, CCC-SLP 102 N Jordan Ave, Miles City, MT 59301-3717 Ph: (406) 853-2971 |
News Archive
GeckoSystems Intl. Corp. announced today that since their first annual "Mobile Robots in Motion" conference earlier this month, they have been solicited by another first tier contract manufacturer interested in the high volume manufacture of their product line. GeckoSystems is a dynamic leader in the emerging Mobile Service Robot industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."
A gene known to promote longevity in animals has now been discovered to encode a tumor suppressor – a protein that helps prevent cancer, according to a study by a team of scientists from The University of Texas M. D. Anderson Cancer Center. The new gene, which was inactivated in two-thirds of patients studied, presents a potent new target for breast cancer therapy, the researchers say.
Around 13 per cent of hospitals have a primary care unit within the emergency department and 6 per cent have a free standing primary care unit.
Avicena Group has announced day that it has filed a composition of matter patent application with the United States Patent and Trademark Office (USPTO) to cover potential treatments for Huntington's disease, a fatal neurodegenerative disease.
A University of Ottawa study has found a specific Alzheimer's treatment is effective in male and not female mice, providing a window into the biology of the disease and the effectiveness of targeted treatments.
› Verified 8 days ago
Tana Thorley Whicker, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 205 S Haynes Ave Unit 2, Miles City, MT 59301 Phone: 406-233-4327 Fax: 406-233-3985 | |
Marilyn Joyce Thaden, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Rr 2 Box 3151, Miles City, MT 59301 Phone: 406-234-5275 | |
Pearl Hamano, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Wilson St, Therapy Services Dept., Miles City, MT 59301 Phone: 406-233-2719 | |
Sarah Lynn Waarvik, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 611 S Strevell Ave, Miles City, MT 59301 Phone: 406-370-0116 | |
Joanna Buchholz, MS-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2200 Box Elder St, Miles City, MT 59301 Phone: 406-234-6034 Fax: 406-234-7018 | |
Amanda Maureen Bastian, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 205 S Haynes Ave, Miles City, MT 59301 Phone: 406-233-4327 | |
Megan M Emmons, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Wilson Street, Miles City, MT 59301 Phone: 406-233-2719 |